Rhabdoid tumors are aggressive and rare cancers primarily affecting infants and young children. They most commonly occur in the kidneys, but can also develop in the brain, spinal cord, or other soft tissues. These tumors are characterized by their fast growth and tendency to spread to other parts of the body. Despite advances in cancer research, treatment options for rhabdoid tumors remain limited, and they often have poor outcomes.
Researchers are actively studying the genetic and molecular mechanisms underlying rhabdoid tumors to develop more effective treatments. Recent studies have identified specific genetic mutations associated with these tumors, providing potential targets for precision therapies. Immunotherapy, which harnesses the body's immune system to fight cancer, is also being explored as a promising treatment approach. Continued research efforts are crucial to improving outcomes for patients with rhabdoid tumors and advancing our understanding of this complex disease.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States